TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34622344

Group type: EXPERIMENTAL
Intervention: rtfMRI neurofeedback (NF) training
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 52
Study: 33291229

Group type: EXPERIMENTAL
Intervention: Specific Carbohydrate Diet (SCD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Modified Specific Carbohydrate Diet (MSCD)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Whole Foods Diet (WF)
Number of subjects: 18
Study: 35040942

Group type: EXPERIMENTAL
Intervention: SRT (short-course radiotherapy of 5 × 5 Gy with surgery within 1 week)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: SRT-delay (short-course radiotherapy of 5 × 5 Gy with surgery after 4-8 weeks)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: LRT-delay (long-course radiotherapy of 25 × 2 Gy with surgery after 4-8 weeks)
Number of subjects: 840

Group type: COMPARATOR
Intervention: SRT (short-course radiotherapy of 5 × 5 Gy)
Number of subjects: 840

Group type: COMPARATOR
Intervention: SRT-delay (short-course radiotherapy of 5 × 5 Gy)
Number of subjects: 840

Group type: COMPARATOR
Intervention: LRT-delay (long-course radiotherapy of 25 × 2 Gy)
Number of subjects: 840

Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 840
Study: 32800403

Group type: EXPERIMENTAL
Intervention: Polygonal template for intraoperative guidance
Number of subjects: 50
Study: 34024196

Group type: EXPERIMENTAL
Intervention: Orchid drug-coated balloon (coated with paclitaxel)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty
Number of subjects: 60

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 60
Study: 33985991

Group type: EXPERIMENTAL
Intervention: Lumasiran (0.3-6 mg/kg single dose for healthy participants; up to 3 doses of 1 or 3 mg/kg monthly or 3 mg/kg quarterly for patients)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Lumasiran
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32746825

Group type: EXPERIMENTAL
Intervention: Specialised palliative homecare (SPHC) support
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Specialised palliative homecare (SPHC) availability
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Extent of engagement in palliative care
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Quality of utilised SPHC
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Involvement in treatment of palliative patients after SPHC initiation
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: Conviction that palliative care should be a central part of GPs' work
Number of subjects: 1026

Group type: EXPERIMENTAL
Intervention: SPHC referrals
Number of subjects: 1026
Study: 36301168

Group type: EXPERIMENTAL
Intervention: Fire needling group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Filiform needling group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Comparison between fire needling and filiform needling groups
Number of subjects: 66
Study: 34338710

Group type: EXPERIMENTAL
Intervention: selfBACK app (tailored self-management support system)
Number of subjects: 461

Group type: COMPARATOR
Intervention: usual care (control group)
Number of subjects: 461
Study: 35708715

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 17589

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17589

Group type: EXPERIMENTAL
Intervention: Ezetimibe (projected use)
Number of subjects: 17589
Study: 34383537

Group type: EXPERIMENTAL
Intervention: DESTRESS-WV (online, coach-assisted cognitive behavioral intervention)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: DESTRESS-WV
Number of subjects: 102

Group type: COMPARATOR
Intervention: Phone monitoring only
Number of subjects: 102
Study: 35421127

Group type: EXPERIMENTAL
Intervention: Adherence to dietary counselling
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Food security status
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Diabetes knowledge
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Lack of access to information
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Moderately food insecure
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Severely food insecure
Number of subjects: 602
Study: 33810477

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation focused on sustained attention through the NeuronUP platform, 3 days a week for 4 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 100
Study: 32487592

Group type: EXPERIMENTAL
Intervention: Implementation of dehydration evidence-based guidelines (EBG)
Number of subjects: 7145
Study: 35440358

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy for Suicide Prevention (CTSP) + Treatment as Usual (TAU)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) alone
Number of subjects: 150
Study: 34992754

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural grief therapy (ICBGT)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Waitlist-control group (WCG)
Number of subjects: 58
Study: 32967883

Group type: EXPERIMENTAL
Intervention: SBRT with atezolizumab
Number of subjects: 103

Group type: COMPARATOR
Intervention: SBRT alone
Number of subjects: 103
Study: 34736438

Group type: EXPERIMENTAL
Intervention: Ropivacaine with intravenous S-ketamine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Ropivacaine only
Number of subjects: 80
Study: 32074702

Group type: EXPERIMENTAL
Intervention: Health belief model-based health education intervention (3 lectures of 20-30 min each)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Health belief model-based health education intervention
Number of subjects: 400
Study: 35300564

Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus paracasei N1115 (2×10^10 cfu/g, 2 g/day)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (maltodextrin, 2 g/day)
Number of subjects: 101
Study: 34102091

Group type: EXPERIMENTAL
Intervention: Feminine/communal video
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Masculine/agentic video
Number of subjects: 482

Group type: COMPARATOR
Intervention: No video (no exposure)
Number of subjects: 482
Study: 33036946

Group type: EXPERIMENTAL
Intervention: Pressure-Controlled Ventilation (PCV)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Volume-Controlled Ventilation (VCV)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both PCV and VCV
Number of subjects: 66
Study: 35267032

Group type: EXPERIMENTAL
Intervention: Semistructured interviews with female chairs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Semistructured interviews with male chairs
Number of subjects: 20
Study: 32993325

Group type: EXPERIMENTAL
Intervention: Plaster-of-Paris casts
Number of subjects: 46

Group type: COMPARATOR
Intervention: Woodcast splints
Number of subjects: 46
Study: 33694345

Group type: EXPERIMENTAL
Intervention: Mindfulness audio recording
Number of subjects: 39

Group type: COMPARATOR
Intervention: History audio recording
Number of subjects: 39
Study: 32945739

Group type: EXPERIMENTAL
Intervention: Inoculated with Ralstonia solanacearum species complex (RSSC) phylotype I strain GMI1000 at a concentration of 10^8 CFU/mL, using soil soak method.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water treated plants (negative control).
Number of subjects: 0
Study: 35469358

Group type: EXPERIMENTAL
Intervention: Shared decision-making (SDM) intervention for diabetes prevention
Number of subjects: 24
Study: 33942563

Group type: EXPERIMENTAL
Intervention: Culturally informed treatment based on Intervention Mapping (IM); 4 sessions, each under 1 hour
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 35279447

Group type: EXPERIMENTAL
Intervention: Higher initial foster carer commitment
Number of subjects: 144
Study: 34784124

Group type: EXPERIMENTAL
Intervention: 1927 nm thulium fiber laser with 0.05% tretinoin lotion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle group (no tretinoin lotion)
Number of subjects: 0
Study: 32539506

Group type: EXPERIMENTAL
Intervention: Vancomycin or daptomycin with an antistaphylococcal β-lactam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (vancomycin or daptomycin without β-lactam)
Number of subjects: 0
Study: 36088385

Group type: EXPERIMENTAL
Intervention: ICU liaison nurse services (patient support, family support, training, support of the ward's staff, evaluation of the destination ward)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine transfer care (control group)
Number of subjects: 60
Study: 32139254

Group type: EXPERIMENTAL
Intervention: Dairy diet
Number of subjects: 30
Study: 35419116

Group type: EXPERIMENTAL
Intervention: Double-heart nursing combined with seaweed polysaccharide
Number of subjects: 214

Group type: COMPARATOR
Intervention: Seaweed polysaccharide
Number of subjects: 214
Study: 33545764

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (Ensure®) daily in addition to daily routine diets after discharge
Number of subjects: 60

Group type: COMPARATOR
Intervention: Regular diets after discharge
Number of subjects: 60
Study: 32500862

Group type: EXPERIMENTAL
Intervention: D-PLEX500 (biodegradable prolonged release local doxycycline with β-tricalcium phosphate bone graft)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: D-PLEX500
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (no D-PLEX500)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 33860350

Group type: EXPERIMENTAL
Intervention: Endoscopic full-thickness resection (FTR)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Endoscopic submucosal dissection (ESD)
Number of subjects: 102
Study: 33648623

Group type: EXPERIMENTAL
Intervention: Permissive hypotension (mean arterial pressure target of 60-65 mmHg)
Number of subjects: 2463

Group type: COMPARATOR
Intervention: Usual care (mean arterial pressure target at clinician's discretion)
Number of subjects: 2463

Group type: EXPERIMENTAL
Intervention: Permissive hypotension
Number of subjects: 2463

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2463
Study: 32517755

Group type: EXPERIMENTAL
Intervention: Physical function (measured by SPPB) and lean body mass (LBM)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Physical function (measured by SPPB) and perceived difficulty in walking outdoors
Number of subjects: 81
Study: 36477612

Group type: EXPERIMENTAL
Intervention: Endoscopic balloon cryoablation (EBCA) after transurethral resection (TUR)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Single instillation (SI) of pirarubicin after transurethral resection (TUR)
Number of subjects: 205
Study: 33621471

Group type: EXPERIMENTAL
Intervention: 4-dose intramuscular Essen regimen
Number of subjects: 70

Group type: COMPARATOR
Intervention: 5-dose intramuscular Essen regimen
Number of subjects: 70
Study: 32800081

Group type: EXPERIMENTAL
Intervention: Alcoholic beverage (target peak breath alcohol concentration = .08%)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Control (non-alcoholic beverage)
Number of subjects: 297
Study: 35589854

Group type: EXPERIMENTAL
Intervention: Rituximab (anti-CD20 monoclonal antibody)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Tocilizumab (anti-IL6R monoclonal antibody)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Multidrug resistance
Number of subjects: 164
Study: 34031690

Group type: EXPERIMENTAL
Intervention: Second-source verification conducted on PTA medication list
Number of subjects: 200
Study: 35083924

Group type: EXPERIMENTAL
Intervention: Molecularly stratified sub-trial (FOCUS4-B, C, or D)
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: FOCUS4-D (AZD8931 in BRAF-PIK3CA-RAS wildtype subgroup)
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: FOCUS4-B (Aspirin in PIK3CA mutant subgroup)
Number of subjects: 1434

Group type: EXPERIMENTAL
Intervention: FOCUS4-C (Adavosertib in RAS+TP53 double mutant subgroup)
Number of subjects: 1434

Group type: COMPARATOR
Intervention: FOCUS4-N (Capecitabine monotherapy)
Number of subjects: 1434
Study: 33611239

Group type: EXPERIMENTAL
Intervention: Smartphone application
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard of care (written information)
Number of subjects: 90
Study: 34626838

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Bevacizumab plus Carboplatin and Paclitaxel (ABCP)
Number of subjects: 1202

Group type: EXPERIMENTAL
Intervention: Atezolizumab plus Carboplatin and Paclitaxel (ACP)
Number of subjects: 1202

Group type: COMPARATOR
Intervention: Bevacizumab plus Carboplatin and Paclitaxel (BCP)
Number of subjects: 1202
Study: 34147123

Group type: EXPERIMENTAL
Intervention: Switching strategy to TNFi based on adalimumab serum trough level
Number of subjects: 84

Group type: COMPARATOR
Intervention: Random allocation to treatment (control group)
Number of subjects: 84
Study: 33559864

Group type: EXPERIMENTAL
Intervention: PSV50
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: NAVA50
Number of subjects: 16

Group type: COMPARATOR
Intervention: NAVA150
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: PSV150
Number of subjects: 16
Study: 33931843

Group type: EXPERIMENTAL
Intervention: Neobladder function training based on the action research method
Number of subjects: 68

Group type: COMPARATOR
Intervention: Neobladder function training
Number of subjects: 68
Study: 35792689

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no ESPB)
Number of subjects: 20
Study: 34444766

Group type: EXPERIMENTAL
Intervention: Sesame oil cake extract (SOCE) for 12 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 70
Study: 33157152

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 35094258

Group type: EXPERIMENTAL
Intervention: Preoperative administration of celecoxib
Number of subjects: 106

Group type: COMPARATOR
Intervention: Postoperative administration of celecoxib
Number of subjects: 106
Study: 32456230

Group type: EXPERIMENTAL
Intervention: Tocovid (200 mg twice a day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (twice a day)
Number of subjects: 80
Study: 35986358

Group type: EXPERIMENTAL
Intervention: Livogen Plus® (nutraceutical) - 6 softgel capsules daily for 12 weeks
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (maltodextrin) - 6 softgel capsules daily for 12 weeks
Number of subjects: 140
Study: 33174314

Group type: EXPERIMENTAL
Intervention: Expiratory Resistance Breathing (ERB) with varying stenosis diameters (3 mm, 2 mm, 1.5 mm)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Metronome-paced tachypnoea (MPT)
Number of subjects: 14
Study: 34905434

Group type: EXPERIMENTAL
Intervention: Cultural Formulation Interview (CFI+AAU)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Assessment as Usual (AAU)
Number of subjects: 89
Study: 35210384

Group type: EXPERIMENTAL
Intervention: Phacoemulsification
Number of subjects: 52

Group type: COMPARATOR
Intervention: Phacotrabeculectomy
Number of subjects: 52
Study: 33228827

Group type: EXPERIMENTAL
Intervention: Thyme (20 g/head/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Celery (20 g/head/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Thyme + Celery (10 g each/head/day)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Salinomycin (1 g/head/day)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control
Number of subjects: 75
Study: 35804379

Group type: EXPERIMENTAL
Intervention: Smartphone app for homework assignments
Number of subjects: 35

Group type: COMPARATOR
Intervention: Paper-and-pencil method for homework assignments
Number of subjects: 35
Study: 34929798

Group type: EXPERIMENTAL
Intervention: 5ml ginger oil applied five days before until the second day of the first menstrual period
Number of subjects: 64

Group type: COMPARATOR
Intervention: 5ml ginger oil applied in the next period
Number of subjects: 64
Study: 35614482

Group type: EXPERIMENTAL
Intervention: Artesunate 100 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Artesunate 50 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33947587

Group type: EXPERIMENTAL
Intervention: Care pathway treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 36316841

Group type: EXPERIMENTAL
Intervention: Comprehensive therapy of traditional Chinese medicine (CTTCM)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Tadalafil
Number of subjects: 108
Study: 33354954

Group type: EXPERIMENTAL
Intervention: Green Model intervention
Number of subjects: 120
Study: 33902646

Group type: EXPERIMENTAL
Intervention: Interactive telerehabilitation using a Kinect camera-based system
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional one-on-one physiotherapy
Number of subjects: 30
Study: 32556507

Group type: COMPARATOR
Intervention: Non-abuse context vignette
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Abuse context vignette
Number of subjects: 172
Study: 34718403

Group type: EXPERIMENTAL
Intervention: Combined weight loss and sodium reduction
Number of subjects: 975

Group type: EXPERIMENTAL
Intervention: Sodium reduction alone
Number of subjects: 975

Group type: COMPARATOR
Intervention: Drug withdrawal (DW)
Number of subjects: 975

Group type: COMPARATOR
Intervention: Usual care (neither weight loss nor sodium reduction)
Number of subjects: 975
Study: 34157349

Group type: EXPERIMENTAL
Intervention: Early CPAP
Number of subjects: 810

Group type: COMPARATOR
Intervention: Early intubation for surfactant administration
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 810
Study: 36035830

Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Routine medical consultation (Control)
Number of subjects: 155
Study: 32128625

Group type: EXPERIMENTAL
Intervention: Therapeutic Patient Education (TPE) with learning objects (LOs) for 60 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual approach (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Therapeutic Patient Education (TPE) with learning objects (LOs)
Number of subjects: 0
Study: 34919025

Group type: EXPERIMENTAL
Intervention: Structured education and follow-up
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no structured education and follow-up)
Number of subjects: 64
Study: 34172029

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT), delivered in five sessions, in-person
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Qualitative feedback from participants and hospice staff
Number of subjects: 10
Study: 36146092

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (IVR) exergame program for 10 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 34039193

Group type: EXPERIMENTAL
Intervention: Personalized video of surgery
Number of subjects: 97

Group type: COMPARATOR
Intervention: No video (Control)
Number of subjects: 97
Study: 33685232

Group type: EXPERIMENTAL
Intervention: Structured counselling-based intervention (interview at week 0, telephone counselling at weeks 1, 3, and 12)
Number of subjects: 89

Group type: COMPARATOR
Intervention: General physical activity guidelines for cancer survivors (week 0)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Structured counselling-based intervention
Number of subjects: 89

Group type: COMPARATOR
Intervention: General physical activity guidelines for cancer survivors
Number of subjects: 89
Study: 32894896

Group type: EXPERIMENTAL
Intervention: Novice evaluators reviewing <30 dual stain slides
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Novice evaluators reviewing 300 dual stain slides
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Novice evaluators reviewing ≥500 dual stain slides
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall concordance for all novice evaluators
Number of subjects: 50
Study: 36191598

Group type: EXPERIMENTAL
Intervention: Community dialogue approach for disseminating trial results
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of local language, pictures, images, and familiar analogies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community interpretation of trial results
Number of subjects: 0
Study: 33957892

Group type: EXPERIMENTAL
Intervention: Geometric average hazard ratio (gAHR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Logrank test for composite endpoint (CE)
Number of subjects: 0
Study: 34732099

Group type: EXPERIMENTAL
Intervention: Bright blue-green light therapy (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dim red light therapy (control group)
Number of subjects: 0
Study: 34437554

Group type: EXPERIMENTAL
Intervention: 5C scale (Arabic version)
Number of subjects: 350
Study: 35180096

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Manipulation Therapy (MT)
Number of subjects: 20
Study: 34092586

Group type: EXPERIMENTAL
Intervention: Apis dorsata Honey (13 ml, 1 tablespoon × 3 for 15 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no honey)
Number of subjects: 30
Study: 36017024

Group type: EXPERIMENTAL
Intervention: CT scan combined with MRI diagnostic method
Number of subjects: 236

Group type: COMPARATOR
Intervention: MRI multiphase dynamic enhancement scan diagnostic method
Number of subjects: 236
Study: 32142371

Group type: EXPERIMENTAL
Intervention: Smartphone-linked home BP monitoring
Number of subjects: 826000

Group type: COMPARATOR
Intervention: Standard home BP monitoring
Number of subjects: 826000

Group type: EXPERIMENTAL
Intervention: BP control quality improvement program version 1
Number of subjects: 826000

Group type: COMPARATOR
Intervention: BP control quality improvement program version 2
Number of subjects: 826000

Group type: EXPERIMENTAL
Intervention: Overall BP control
Number of subjects: 826000

Group type: EXPERIMENTAL
Intervention: High BP measurement response
Number of subjects: 826000
Study: 34718382

Group type: EXPERIMENTAL
Intervention: Mediterranean diet made entirely from organic foods
Number of subjects: 27

Group type: COMPARATOR
Intervention: Mediterranean diet made entirely from conventional foods
Number of subjects: 27